Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of B lymphocytes aberrantly expressing CD5+ in peripheral blood, bone marrow, and secondary lymphoid organs (lymph nodes and spleen) [1,2,3,4]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.